Medi3 is a shop in Antwerpen. Private Limited, started on 27 April 2015, 1 establishment.

What is the address of Medi3?

The registered office of Medi3 is located at Ballaarstraat 100 box 3, 2018 Antwerpen.

Is Medi3 still active?

Yes. According to the CBE (2 November 2026) Medi3 is active, legal situation “Normale toestand”, started on 27 April 2015.

Is Medi3 registered on Peppol?

Yes, Medi3 is registered on the Peppol network with ID 0208:0628890986.

What is the enterprise number of Medi3?

The enterprise number of Medi3 is BE0628890986.

When was Medi3 founded?

Medi3 was founded on 27 April 2015.

Who are the directors of Medi3?

According to the 2025 annual accounts, the directors of Medi3 are: CCare BV, D-MANUFACTURING BV.

Is Medi3 a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 April 2015; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Medi3 make in 2025?

Medi3 posted a profit after taxes of € 33,914 in financial year 2025.

What is the revenue of Medi3?

As a small company, Medi3 is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 36,224.

How many employees does Medi3 have?

According to the 2025 annual accounts, Medi3 has 0 full-time equivalents (FTE).

Medi3 (Private Limited) - Antwerpen - BE0628890986

Dossier Medi3, printed on 2 November 2026 from databakkes.be/en/0628890986/medi3. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Medi3 from Antwerpen, company number BE0628890986, closed financial year 2025 with a result of € 33,914 after tax. For that financial year Medi3 recorded a gross margin of € 36,224 and equity of € 151,792. Compared with financial year 2024, the result moved from € -10,647 to € 33,914. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What it is worth Growing

€ 151,792

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 33,914

▲ still € 10,647 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 44,084

▲ 92% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 30,000 paid out

88 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 16,561

▼ 38% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3

▲ 21% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 6,903 Gross margin 2022: € 6,903 First fiscal year in the series	€ 51,713 Gross margin 2023: € 51,713 ▲ € 44,809 vs 2022 (€ 6,903) Favourable step	€ -9,275 Gross margin 2024: € -9,275 ▼ € 60,988 vs 2023 (€ 51,713) Unfavourable step	€ 36,224 Gross margin 2025: € 36,224 ▲ € 45,500 vs 2024 (€ -9,275) Favourable step	▲ € 45,500
Profit after taxes	€ 7,325 Profit after taxes 2022: € 7,325 First fiscal year in the series	€ 51,897 Profit after taxes 2023: € 51,897 ▲ € 44,572 vs 2022 (€ 7,325) Favourable step	€ -10,647 Profit after taxes 2024: € -10,647 ▼ € 62,544 vs 2023 (€ 51,897) Unfavourable step	€ 33,914 Profit after taxes 2025: € 33,914 ▲ € 44,561 vs 2024 (€ -10,647) Favourable step	▲ € 44,561
Equity	€ 149,628 Equity 2022: € 149,628 First fiscal year in the series	€ 158,525 Equity 2023: € 158,525 ▲ 6% vs 2022 (€ 149,628) Favourable step	€ 147,878 Equity 2024: € 147,878 ▼ 7% vs 2023 (€ 158,525) Unfavourable step	€ 151,792 Equity 2025: € 151,792 ▲ 3% vs 2024 (€ 147,878) Favourable step	▲ 3%
Total debts	€ 25,659 Total debts 2022: € 25,659 First fiscal year in the series	€ 71,694 Total debts 2023: € 71,694 ▲ 179% vs 2022 (€ 25,659) Unfavourable step	€ 27,420 Total debts 2024: € 27,420 ▼ 62% vs 2023 (€ 71,694) Favourable step	€ 54,563 Total debts 2025: € 54,563 ▲ 99% vs 2024 (€ 27,420) Unfavourable step	▲ 99%
Cash	€ 17,181 Cash 2022: € 17,181 First fiscal year in the series	€ 33,658 Cash 2023: € 33,658 ▲ 96% vs 2022 (€ 17,181) Favourable step	€ 23,006 Cash 2024: € 23,006 ▼ 32% vs 2023 (€ 33,658) Unfavourable step	€ 44,084 Cash 2025: € 44,084 ▲ 92% vs 2024 (€ 23,006) Favourable step	▲ 92%
Retained profit	€ 129,168 Retained profit 2022: € 129,168 First fiscal year in the series	€ 138,065 Retained profit 2023: € 138,065 ▲ 7% vs 2022 (€ 129,168) Favourable step	€ 127,418 Retained profit 2024: € 127,418 ▼ 8% vs 2023 (€ 138,065) Unfavourable step	€ 131,332 Retained profit 2025: € 131,332 ▲ 3% vs 2024 (€ 127,418) Favourable step	▲ 3%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 43,000 Dividend 2023: € 43,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 43,000) Unchanged	€ 30,000 Dividend 2025: € 30,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 175,287 Balance sheet total 2022: € 175,287 First fiscal year in the series	€ 230,218 Balance sheet total 2023: € 230,218 ▲ 31% vs 2022 (€ 175,287) Unchanged	€ 175,298 Balance sheet total 2024: € 175,298 ▼ 24% vs 2023 (€ 230,218) Unchanged	€ 206,355 Balance sheet total 2025: € 206,355 ▲ 18% vs 2024 (€ 175,298) Unchanged	▲ 18%

Key figures of Medi3, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Medi3?

What happened at Medi3 in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 16, 2026 New annual accounts for financial year 2025: profit of € 33,914. Source: NBB ↗
2016 CCare BV became a director. NBB
2016 D-MANUFACTURING BV became a director. NBB
Jul 1, 2015 New establishment in Antwerpen. KBO
Apr 27, 2015 Start of the company according to the CBE. KBO

In short

From € 7,325 profit in 2022 to € 33,914 profit in 2025.

Paid € 1,005 in corporate taxes since 2022.

Best year ever: 2023, with € 51,897 profit.

Paid out € 73,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Caroline Keusters 33.3%

Nadine Vanderbeken 33.3%

CCare 16.7%

D-MANUFACTURING 16.7%

Medi3

Behind Medi3 are CCare BV and D-MANUFACTURING BV. The shares are held by Caroline Keusters (33.3%), Nadine Vanderbeken (33.3%), CCare (16.7%) and D-MANUFACTURING (16.7%).

Directors

According to the 2025 annual accounts

CCare BV

Director · represented by Keusters Caroline

since 2016

D-MANUFACTURING BV

Director · represented by Vanderbeken Nadine

since 2016

Shareholders

Caroline Keusters

33.3%

Nadine Vanderbeken

33.3%

CCare

16.7%

D-MANUFACTURING

16.7%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Ballaarstraat 100 box 3

2018 Antwerpen

2.244.362.145

Ballaarstraat 100

2018 Antwerpen

Active since 1 July 2015

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

D-MANUFACTURING same network

€ 22,165 gross margin · 2025

Vereniging van Mede-eigenaars Residentie MONA te Antwerpen, Ballaarstraat 100

MECANIQUE GENERIC

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0628.890.986

VAT number

BE 0628.890.986

Registered office

Ballaarstraat 100 bus 3, 2018 Antwerpen

Names & denominations

Medi3

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 April 2015

Peppol

Active · Active since 21 Oct 2026

Activities · NACE

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Medi3

Financials

What happened to Medi3?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions